Clinical Trials Sponsored by Ellen Bøhmer

Total 129 results

Ellen Bøhmer

Unknown

An Observational Study of Stroke Patients. (SPET-72)

Hyperglycemia | Cerebrovascular Disorders | Hypertension | Troponin | Quality of Care

Norway
Fondation Ellen Poidatz

Recruiting

Serious Game-based Intervention in Gait Rehabilitation for Children With Cerebral Palsy

Cerebral Palsy | Gait Disorders, Neurologic

France
Fondation Ellen Poidatz

Recruiting

Protocol Validation of Dynamometric Measurement of Passive Inter-segmental Stiffness and Spasticity in Children With Cerebral Palsy

Cerebral Palsy

France
Fondation Ellen Poidatz

Recruiting

Intensive Gait Training Rehabilitation Protocol After Surgery in Cerebral Palsy (ACTIV'MARCHE)

Cerebral Palsy

France
Wiebe, Ellen, M.D.

Completed

GyneFix-Viz*: A Study of Serosal-Anchor (SA) Distance (GF)

Contraception

Canada
Wiebe, Ellen, M.D.

Completed

A Pilot Study of Early Expulsion Rates of the IUB™ SCu380A (IUB)

Contraception

Canada
Wiebe, Ellen, M.D.
Ibis Reproductive Health

Completed

Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion

Unwanted Pregnancies

Canada
Ellen Mitchell

Terminated

Visual Information Restoration and Rehabilitation Via Sensory Substitution Technology in Children

Blindness

United States
Ellen Spurrier
Mallinckrodt

Completed

The Effects of Inhaled Nitric Oxide After Fontan Operation

Congenital Heart Defect

United States
Fondation Ellen Poidatz
Université Paris-Sud

Completed

Feedback in Augmented Reality to Control of Gait Parameters in Children With Cerebral Palsy (BestOf_ARRoW)

Cerebral Palsy | Gait Disorders, Neurologic | Feedback, Psychological

France
Yellen & Associates, Inc.

Withdrawn

Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism

Autistic Disorder | Asperger Syndrome | Autism, Early Infantile | Autism, Infantile

United States
Elpen Pharmaceutical Co. Inc.

Completed

Carvedilol Vascular Efficacy Trial (CARVEDIA)

Heart Failure | Acute Myocardial Infarction

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy (IFAISTOS)

Fatigue | Iron-deficiency | Anemia | Iron Deficiency Anemia
Elpen Pharmaceutical Co. Inc.

Withdrawn

Adherence of Iron Succinylate Therapy in Pregnancy (ARTEMIS)

Pregnancy Related | Pregnancy Anemia | Iron Deficiency Anemia

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Prospective evAluatIon foR Inhalation Devices Study (PAIR)

Asthma | COPD

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis (GRegistry SCDU)

Scleroderma | Digital Ulcer | Systematic Sclerosis

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension (BOTA-PAH)

Pulmonary Hypertension
Elpen Pharmaceutical Co. Inc.

Withdrawn

COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF (COPPER-AF)

Atrial Fibrillation
Elpen Pharmaceutical Co. Inc.

Completed

Eplerenone in Heart Failure Treatment (INOSET)

Heart Failure | Hypertension | Acute Myocardial Infarction

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events (EKVASIS)

Cardiovascular Disorders

Greece
Elpen Pharmaceutical Co. Inc.

Completed

ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment) (ANASA)

Chronic Obstructive Pulmonary Disease | Asthma

Greece
Ellen Evans
Kellogg Company

Completed

Effect of Dihydrocapsiate on Energy Expenditure in Women

Obesity

United States
Elpen Pharmaceutical Co. Inc.

Not yet recruiting

QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt. (TRITON)

COPD
Elpen Pharmaceutical Co. Inc.

Not yet recruiting

TorasEmide Induced Effect on Quality of Life and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. (ESTIA)

Chronic Heart Failure
Elpen Pharmaceutical Co. Inc.

Recruiting

Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice. (ARGO)

Copd | COPD Exacerbation

Greece
Elpen Pharmaceutical Co. Inc.

Recruiting

Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. (CURE)

Autoimmune Diseases | Diffuse Cutaneous Systemic Sclerosis | Scleroderma | Digital Ulcer | Reynold Syndrome

Greece
Elpen Pharmaceutical Co. Inc.

Completed

AdHerencE to Treatment and quAlity of Life in COPD (AHEAD)

Quality of Life | Chronic Obstructive Pulmonary Disease | Compliance, Patient

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®

Asthma

Czechia
Elpen Pharmaceutical Co. Inc.

Completed

Multiple Electrode Aggregometry & Clopidogrel Resistance

Coronary Artery Disease (CAD) | Type 2 Diabetes Mellitus (T2DM) | Myocardial Infraction

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation (PRESERVE-SR)

Recurrence | Atrial Fibrillation
Elpen Pharmaceutical Co. Inc.

Completed

PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT (PLATINUM)

Quality of Life | Dyslipidemias | Hyperlipidemias | Risk Factor, Cardiovascular

Greece
Elpen Pharmaceutical Co. Inc.

Completed

EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece (AEOLOS)

Chronic Obstructive Pulmonary Disease

Greece
Elpen Pharmaceutical Co. Inc.

Completed

COMPLliancE and qualiTy of lifE in Asthma (COMPLETE)

Quality of Life | Asthma | Compliance, Patient

Greece
Elpen Pharmaceutical Co. Inc.

Completed

eVAluatIon of OLanzapine TreatmEnT (VIOLET)

Schizophrenia | Bipolar Disorder

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Osteoporosis Screening Trial (OSTRIA)

Osteoporosis

Greece
Elpen Pharmaceutical Co. Inc.

Completed

A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method. (INSPIRE)

Pulmonary Disease

Greece
Mary Ellen Vajravelu, MD

Completed

Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation

Insulin Resistance | PreDiabetes | Overweight and Obesity

United States
Elpen Pharmaceutical Co. Inc.

Recruiting

Ezetimibe-Rosuvastatin Evaluation Study (ZEUS)

Hypercholesterolemia | Hyperlipidemias | Combinations of Drugs; Dependence

Greece
Elpen Pharmaceutical Co. Inc.

Completed

A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination (RETRIEVE)

COPD | COPD Exacerbation

Greece
Elpen Pharmaceutical Co. Inc.

Completed

AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice. (NOTOS)

Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II) (PROSPERITY)

Benign Prostatic Hyperplasia

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler

Asthma
Elpen Pharmaceutical Co. Inc.

Completed

Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice. (BOREAS)

Quality of Life | Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure (THETIS)

Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV
Elpen Pharmaceutical Co. Inc.

Withdrawn

Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation

Atrial Fibrillation

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety disOrders in the Greek populatIon (PRONOI)

Depression | Anxiety Disorders

Greece
Elpen Pharmaceutical Co. Inc.

Completed

10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection

Helicobacter Pylori Infection

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice (SKIRON)

Quality of Life | Asthma | Satisfaction

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

Hypertension | Diabetes Mellitus | Renal Insufficiency | Sleep Apnea | Cardiac Arrhythmias

Greece
Elpen Pharmaceutical Co. Inc.

Completed

LevetIracetam in Patients Being Treated for Epilepsy (LIBERTY)

Epilepsy

Greece

3

Subscribe